• OPEN AN ACCOUNT
Indian Indices
Sensex
74,459.53 308.49
( 0.42%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
41.2
993.8
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.06
 

satani bearings ltd
Swati Projects reports consolidated net profit of Rs 1.93 crore in the March 2026 quarter
Jun 01,2026
Net profit of Swati Projects reported to Rs 1.93 crore in the quarter ended March 2026 as against net loss of Rs 0.13 crore during the previous quarter ended March 2025. Sales rose 4388.24% to Rs 7.63 crore in the quarter ended March 2026 as against Rs 0.17 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 7.16 crore in the year ended March 2026 as against net loss of Rs 0.13 crore during the previous year ended March 2025. Sales rose 2324.82% to Rs 34.19 crore in the year ended March 2026 as against Rs 1.41 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.630.17 4388 34.191.41 2325
OPM %43.91-100.00 -30.3327.66 -
PBDT3.35-0.17 LP 10.370.39 2559
PBT3.29-0.17 LP 10.240.32 3100
NP1.93-0.13 LP 7.16-0.13 LP